Inhibitor Therapeutics, Inc. Dividends Payable, Current
Inhibitor Therapeutics, Inc. (INTI) had Dividends Payable, Current of $250.41 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:DividendsPayableCurrent · last filed 2023-03-31
- 2022-09-30: Dividends Payable, Current $250.41K.
- 2022-06-30: Dividends Payable, Current $200.00K.
- 2022-03-31: Dividends Payable, Current $150.14K.
- 2021-12-31: Dividends Payable, Current $100.82K.
| Period end | Dividends Payable, Current |
|---|---|
| 2022-09-30 | $250.41K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $200.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $150.14K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $100.82K 10-K · filed 2023-03-31 |
| 2021-09-30 | $50.41K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $99.18K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $49.31K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $100.82K 10-K · filed 2022-03-30 |
| 2020-09-30 | $50.41K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $200.55K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $150.69K 10-Q · filed 2020-05-01 |
| 2019-12-31 | $100.82K 10-K · filed 2021-03-26 |
| 2019-09-30 | $50.41K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $99.18K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $49.31K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $99.94K 10-K · filed 2020-03-30 |
| 2018-09-30 | $49.53K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $56.55K 10-Q · filed 2018-07-23 |
| 2018-03-31 | $26.63K 10-Q · filed 2018-05-01 |